Antibiotics - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	69.98%
RATE OF USE
Annual consumption (DDD)	65,148,604
Standardised rate of use (per 100,000 insured persons)	568,230.30
Average annual consumption per patient (DDD)	19.97
% Insured persons concerned	28.46%
Approximate % DDD issued outside the insurance	10.69%
% Patients with more than 3 times the average consumption	4.41%
POPULATION
Median age	51 years
Max/min ratio of the median age (by district)	1.41
Percentage of women	59.88%
Ratio Preferential scheme/General scheme	1.44
CONSUMPTION TRENDS (DDD)
Trend 2011-2021	-4.03%
Trend 2011-2019	-2.13%
Trend 2019-2021	-11.29%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2011-2013	8.99
Coefficient of variation 2019-2021	8.90
Max/min ratio of consumption (DDD per 100,000 insured persons, by region)	1.15
Max/min ratio of consumption ( DDD per 100,000 insured persons, by district)	1.47
DIRECT EXPENDITURE
Annual expenditure charged to the insurance	50,041,501€
Average annual expenditure per insured person	4.36 €
Average patient share (under insurance)	38.74%
Max/min ratio of expenditure per insured person (by region)	1.23
Max/min ratio of expenditure per insured person (by disctrict)	1.61
% “Low-cost” medication	75.53%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES	LABEL	LABEL ATC-5
J01AA01	DEMECLOCYCLINE	TETRACYCLINES
J01AA02	DOXYCYCLINE	TETRACYCLINES
J01AA04	LYMECYCLINE	TETRACYCLINES
J01AA06	OXYTETRACYCLINE	TETRACYCLINES
J01AA07	TETRACYCLINE	TETRACYCLINES
J01AA08	MINOCYCLINE	TETRACYCLINES
J01AA12	TIGECYCLINE	TETRACYCLINES
J01BA02	THIAMPHENICOL	AMPHENICOLES
J01BA52	THIAMPHENICOL, ASSOCIATIONS	AMPHENICOLES
J01CA04	AMOXICILLINE	PENICILLINES A LARGE SPECTRE
J01CE01	BENZYLPENICILLINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE02	PHENOXYMETHYLPENICILLINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE05	PHENETICILLINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE07	CLOMETOCILLINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE08	BENZYLPENICILLINE BENZATHINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE10	PHENOXYMETHYLPENICILLINE BENZATHINE	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CE19	ciclacilline	PENICILLINES SENSIBLES AUX BETA-LACTAMASES
J01CF01	DICLOXACILLINE	PENICILLINES RESISTANTES AUX BETA-LACTAMASES
J01CF02	CLOXACILLINE	PENICILLINES RESISTANTES AUX BETA-LACTAMASES
J01CF04	OXACILLINE	PENICILLINES RESISTANTES AUX BETA-LACTAMASES
J01CF05	FLUCLOXACILLINE	PENICILLINES RESISTANTES AUX BETA-LACTAMASES
J01CR02	AMOXICILLINE ET INHIBITEURS D'ENZYME	ASSOCIATIONS DE PENICILLINES, INHIB. DE LA BETALACTAMASE INCLUS
J01DB01	CEFALEXINE	CEPHALOSPORINES DE LA PREMIERE GENERATION
J01DB04	CEFAZOLINE	CEPHALOSPORINES DE LA PREMIERE GENERATION
J01DB05	CEFADROXIL	CEPHALOSPORINES DE LA PREMIERE GENERATION
J01DB07	CEFATRIZINE	CEPHALOSPORINES DE LA PREMIERE GENERATION
J01DB09	CEFRADINE	CEPHALOSPORINES DE LA PREMIERE GENERATION
J01DC01	CEFOXITINE	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC02	CEFUROXIME	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC03	CEFAMANDOLE	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC04	CEFACLOR	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC05	CEFOTETAN	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC06	CEFONICIDE	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC07	CEFOTIAM	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DC11	CEFORANIDE	CEPHALOSPORINES DE LA DEUXIEME GENERATION
J01DD01	CEFOTAXIME	CEPHALOSPORINES DE LA TROISIEME GENERATION
J01DD02	CEFTAZIDIME	CEPHALOSPORINES DE LA TROISIEME GENERATION
J01DD04	CEFTRIAXONE	CEPHALOSPORINES DE LA TROISIEME GENERATION
J01DD52	J01DD52	CEPHALOSPORINES DE LA TROISIEME GENERATION
J01DH02	MEROPENEM	CARBAPENEMES
J01DH04	DORIPENEM	CARBAPENEMES
J01DH51	IMIPENEM ET INHIBITEURS D'ENZYME	CARBAPENEMES
J01EE01	SULFAMETHOXAZOLE ET TRIMETHOPRIME (CO-TRIMOXAZOLE)	ASSOCIATIONS DE SULFAMIDES ET DE TRIMETHOPRIME, DERIVES INCLUS
J01EE02	SULFADIAZINE ET TRIMETHOPRIME (CO-TRIMAZINE)	ASSOCIATIONS DE SULFAMIDES ET DE TRIMETHOPRIME, DERIVES INCLUS
J01FA01	ERYTHROMYCINE	MACROLIDES
J01FA02	SPIRAMYCINE	MACROLIDES
J01FA06	ROXITHROMYCINE	MACROLIDES
J01FA08	TROLEANDOMYCINE	MACROLIDES
J01FA09	CLARITHROMYCINE	MACROLIDES
J01FA10	AZITHROMYCINE	MACROLIDES
J01FA11	MIOCAMYCINE	MACROLIDES
J01FA13	DIRITHROMYCINE	MACROLIDES
J01FA15	TELITHROMYCINE	MACROLIDES
J01FF01	CLINDAMYCINE	LINCOSANIDES
J01FF02	LINCOMYCINE	LINCOSANIDES
J01GB01	TOBRAMYCINE	AUTRES AMINOGLYCOSIDES
J01GB03	GENTAMICINE	AUTRES AMINOGLYCOSIDES
J01GB04	KANAMYCINE	AUTRES AMINOGLYCOSIDES
J01GB06	AMIKACINE	AUTRES AMINOGLYCOSIDES
J01GB07	NETILMICINE	AUTRES AMINOGLYCOSIDES
J01GB09	DIBEKACINE	AUTRES AMINOGLYCOSIDES
J01GB11	ISEPAMICINE	AUTRES AMINOGLYCOSIDES
J01MA01	OFLOXACINE	FLUOROQUINOLONES
J01MA02	CIPROFLOXACINE	FLUOROQUINOLONES
J01MA03	PEFLOXACINE	FLUOROQUINOLONES
J01MA06	NORFLOXACINE	FLUOROQUINOLONES
J01MA08	FLEROXACINE	FLUOROQUINOLONES
J01MA10	RUFLOXACINE	FLUOROQUINOLONES
J01MA12	LEVOFLOXACINE	FLUOROQUINOLONES
J01MA14	MOXIFLOXACINE	FLUOROQUINOLONES
J01XA01	VANCOMYCINE	GLYCOPEPTIDES
J01XA02	TEICOPLANINE	GLYCOPEPTIDES
J01XB01	COLISTINE	POLYMYXINES
J01XB02	POLYMYXINE B	POLYMYXINES
J01XE01	NITROFURANTOINE	DERIVES DU NITROFURANE
J01XE02	NIFURTOINOL	DERIVES DU NITROFURANE
J01XX01	FOSFOMYCINE	AUTRES ANTIBACTERIENS

The labels on a blue background are the medicines that exist under the status "low cost".
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click here to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.